Aerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals
Compugen Ltd · Now $2.46
-8.7% in 3d after detection
Post-detection moves
1h
—
1d
-4.5%
3d
-8.7%
7d
-2.8%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS